✦ LIBER ✦

Benefit-Risk Assessment of Long-Acting β2-Agonists in Asthma

✍ Scribed by Catherine M. Jackson, Brian Lipworth

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Acting β2-Agonists in Asthma

✍ Dr Graeme P. Currie, Daniel K.C. Lee, Brian J. Lipworth 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 114 KB

Benefits of long-acting β2-agonists

✍ Lipworth, Brian J. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Long-acting β-adrenoceptor agonists incr

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 136 KB

Long-acting β2 agonists and paediatric a

✍ Hans Bisgaard; Stan Szefler 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 45 KB

Long-Acting β-Agonists in Asthma Managem

✍ Satya Mysore, Emeritus Professor Richard E. Ruffin 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 116 KB

A Benefit-Risk Assessment of Inhaled Lon

✍ Dr Milind P. Sovani, Christopher I. Whale, Anne. E. Tattersfield 📂 Article 📅 2004 🏛 Springer International Publishing AG 🌐 English ⚖ 333 KB